IL120056A - History of Naphtali - Google Patents

History of Naphtali

Info

Publication number: IL120056A
Authority: IL; Israel
Prior art keywords: mixture; ch3o; bis; give; group
Prior art date: 1992-02-20

Application number

IL120056A

Other languages

English (en)

Hebrew (he)

Original Assignee

Tanabe Seiyaki Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-20

Filing date

1993-02-18

Publication date

1998-02-08

1993-02-18 Application filed by Tanabe Seiyaki Co filed Critical Tanabe Seiyaki Co

1998-02-08 Publication of IL120056A publication Critical patent/IL120056A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Lubricants (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL120056A 1992-02-20 1993-02-18 History of Naphtali IL120056A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP4085118A JP3042156B2 (ja)	1992-02-20	1992-02-20	ナフタレン誘導体、その製法及びその合成中間体
IL104773A IL104773A (en)	1992-02-20	1993-02-18	Naphthalene derivatives, their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number	Publication Date
IL120056A true IL120056A (en)	1998-02-08

Family

ID=13849719

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
IL104773A IL104773A (en)	1992-02-20	1993-02-18	Naphthalene derivatives, their preparation and pharmaceutical compositions containing them
IL120056A IL120056A (en)	1992-02-20	1993-02-18	History of Naphtali
IL12005797A IL120057A0 (en)	1992-02-20	1997-01-23	Naphthalene derivatives
IL12005697A IL120056A0 (en)	1992-02-20	1997-01-23	Naphthalene derivatives

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IL104773A IL104773A (en)	1992-02-20	1993-02-18	Naphthalene derivatives, their preparation and pharmaceutical compositions containing them

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL12005797A IL120057A0 (en)	1992-02-20	1997-01-23	Naphthalene derivatives
IL12005697A IL120056A0 (en)	1992-02-20	1997-01-23	Naphthalene derivatives

Country Status (17)

Country	Link
US (1)	US5342941A (fi)
EP (1)	EP0557016B1 (fi)
JP (1)	JP3042156B2 (fi)
KR (1)	KR100199121B1 (fi)
CN (1)	CN1045435C (fi)
AT (1)	ATE139528T1 (fi)
AU (1)	AU658046B2 (fi)
CA (1)	CA2089906C (fi)
DE (1)	DE69303191T2 (fi)
DK (1)	DK0557016T3 (fi)
ES (1)	ES2090855T3 (fi)
FI (1)	FI102277B1 (fi)
GR (1)	GR3020294T3 (fi)
HK (1)	HK98997A (fi)
IL (4)	IL104773A (fi)
MY (1)	MY108891A (fi)
TW (1)	TW224458B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL118469A (en) *	1995-06-15	2000-08-13	Tanabe Seiyaku Co	Naphthalene derivatives their preparation and intermediates thereof
ID19155A (id) *	1996-12-13	1998-06-18	Tanabe Seiyaku Co	Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
DE19755480A1 (de) *	1997-12-13	1999-06-24	Gruenenthal Gmbh	Substituierte heterocyclische Benzocycloalkene und ihre Verwendung als analgetisch wirksame Substanzen
JPH11209350A (ja)	1998-01-26	1999-08-03	Eisai Co Ltd	含窒素複素環誘導体およびその医薬
US6465495B1 (en) *	1998-07-30	2002-10-15	Osi Pharmaceuticals, Inc.	Preparation of pyridone-based phosphotyrosine mimetics and uses thereof
TR200909479T2 (tr)	1999-08-21	2012-02-21	Nycomed Gmbh	Sinerjistik kombinasyon.
US20040146561A1 (en)	2001-05-23	2004-07-29	Naoki Sakurai	Compositions for promoting healing of bone fracture
JP4510383B2 (ja)	2001-05-23	2010-07-21	田辺三菱製薬株式会社	軟骨疾患修復治療用組成物
TWI221838B (en)	2001-08-09	2004-10-11	Tanabe Seiyaku Co	Pyrazinoisoquinoline compound or naphthalene compound
CA2517487A1 (en)	2003-04-01	2004-10-14	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
TWI339578B (en)	2004-10-29	2011-04-01	Mitsubishi Tanabe Pharma Corp	Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
WO2007112347A1 (en) *	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
DK2203439T3 (da)	2007-09-14	2011-04-18	Ortho Mcneil Janssen Pharm	1',3'-disubstituerede 4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']-bipyridinyl-2'-oner
US8691849B2 (en)	2008-09-02	2014-04-08	Janssen Pharmaceuticals, Inc.	3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
US8691813B2 (en)	2008-11-28	2014-04-08	Janssen Pharmaceuticals, Inc.	Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
SG176018A1 (en)	2009-05-12	2011-12-29	Janssen Pharmaceuticals Inc	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439008B (zh)	2009-05-12	2015-04-29	杨森制药有限公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298809B (zh)	2010-11-08	2016-08-31	杨森制药公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
ES2552455T3 (es)	2010-11-08	2015-11-30	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
AU2011328195B2 (en)	2010-11-08	2015-04-02	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
ES2748633T3 (es)	2014-01-21	2020-03-17	Janssen Pharmaceutica Nv	Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso
EA033889B1 (ru)	2014-01-21	2019-12-05	Янссен Фармацевтика Нв	Комбинация на основе лиганда sv2a и положительного аллостерического модулятора метаботропного глутаматергического рецептора 2 подтипа

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA825413B (en) *	1981-08-26	1983-06-29	Pfizer	Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4503061A (en) *	1983-07-22	1985-03-05	Warner-Lambert Company	Substituted phenyl-pyridinones as cardiotonic agents
US4661596A (en) *	1985-02-21	1987-04-28	American Home Products Corporation	Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
US4792556A (en) *	1985-09-09	1988-12-20	Syntex (U.S.A.) Inc.	Naphthalene anti-psoriatic agents
WO1989003681A1 (en) *	1987-10-19	1989-05-05	Pfizer Inc.	Substituted tetralins, chromans and related compounds in the treatment of asthma
GB8809481D0 (en) *	1988-04-21	1988-05-25	Smith Kline French Lab	Chemical compounds
DE3837464A1 (de) *	1988-11-04	1990-05-10	Bayer Ag	(hetero)aryloxynaphthalinderivate, verfahren und neue (hetero)aryloxynaphthylamine zu ihrer herstellung sowie ihre verwendung als herbizide
GB8916683D0 (en) *	1989-07-21	1989-09-06	Beecham Group Plc	Novel compounds
US5182296A (en) *	1989-10-26	1993-01-26	Tanabe Seiyaky Co., Ltd.	Naphthyloxazolidone derivatives
AU641769B2 (en) *	1990-06-18	1993-09-30	Merck & Co., Inc.	Inhibitors of HIV reverse transcriptase
EP0489300A3 (en) *	1990-12-05	1993-03-17	J. Uriach & Cia. S.A.	New tetralones with pharmacological activity
US5272170A (en) *	1990-12-05	1993-12-21	J. Uriach & Cia., S.A.	Tetralones with pharmacological activity
FR2671551B1 (fr) *	1991-01-15	1993-03-12	Adir	Nouveaux composes de structure aryl triazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
RU2059603C1 (ru) *	1991-05-09	1996-05-10	Хоффманн-Ля Рош АГ	ПРОИЗВОДНЫЕ α -ЗАМЕЩЕННЫХ АРИЛУКСУСНЫХ КИСЛОТ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ

1992
- 1992-02-20 JP JP4085118A patent/JP3042156B2/ja not_active Expired - Lifetime
1993
- 1993-02-11 AT AT93300998T patent/ATE139528T1/de not_active IP Right Cessation
- 1993-02-11 EP EP93300998A patent/EP0557016B1/en not_active Expired - Lifetime
- 1993-02-11 ES ES93300998T patent/ES2090855T3/es not_active Expired - Lifetime
- 1993-02-11 DE DE69303191T patent/DE69303191T2/de not_active Expired - Fee Related
- 1993-02-11 DK DK93300998.7T patent/DK0557016T3/da active
- 1993-02-11 AU AU32952/93A patent/AU658046B2/en not_active Ceased
- 1993-02-18 IL IL104773A patent/IL104773A/xx not_active IP Right Cessation
- 1993-02-18 TW TW082101129A patent/TW224458B/zh active
- 1993-02-18 IL IL120056A patent/IL120056A/en not_active IP Right Cessation
- 1993-02-18 KR KR1019930002269A patent/KR100199121B1/ko not_active IP Right Cessation
- 1993-02-18 MY MYPI93000270A patent/MY108891A/en unknown
- 1993-02-18 FI FI930711A patent/FI102277B1/fi active
- 1993-02-19 CA CA002089906A patent/CA2089906C/en not_active Expired - Fee Related
- 1993-02-19 US US08/019,885 patent/US5342941A/en not_active Expired - Fee Related
- 1993-02-20 CN CN93102013A patent/CN1045435C/zh not_active Expired - Fee Related
1996
- 1996-06-20 GR GR960401544T patent/GR3020294T3/el unknown
1997
- 1997-01-23 IL IL12005797A patent/IL120057A0/xx unknown
- 1997-01-23 IL IL12005697A patent/IL120056A0/xx unknown
- 1997-06-26 HK HK98997A patent/HK98997A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2089906C (en)	1998-08-18
KR930017851A (ko)	1993-09-20
FI930711A (fi)	1993-08-21
GR3020294T3 (en)	1996-09-30
ATE139528T1 (de)	1996-07-15
IL104773A (en)	1997-07-13
EP0557016B1 (en)	1996-06-19
IL104773A0 (en)	1993-06-10
DE69303191D1 (de)	1996-07-25
AU3295293A (en)	1993-08-26
JPH05229987A (ja)	1993-09-07
TW224458B (fi)	1994-06-01
CN1075957A (zh)	1993-09-08
IL120056A0 (en)	1997-04-15
KR100199121B1 (ko)	1999-06-15
JP3042156B2 (ja)	2000-05-15
ES2090855T3 (es)	1996-10-16
FI930711A0 (fi)	1993-02-18
MY108891A (en)	1996-11-30
HK98997A (en)	1997-08-08
FI102277B (fi)	1998-11-13
FI102277B1 (fi)	1998-11-13
EP0557016A1 (en)	1993-08-25
US5342941A (en)	1994-08-30
DK0557016T3 (da)	1996-07-15
CN1045435C (zh)	1999-10-06
CA2089906A1 (en)	1993-08-21
IL120057A0 (en)	1997-04-15
AU658046B2 (en)	1995-03-30
DE69303191T2 (de)	1996-11-14

Publication	Publication Date	Title
IL120056A (en)	1998-02-08	History of Naphtali
Buckle et al.	1986	Studies on 1, 2, 3-triazoles. 13.(Piperazinylalkoxy)-[1] benzopyrano [2, 3-d]-1, 2, 3-triazol-9 (1H)-ones with combined H1-antihistamine and mast cell stabilizing properties
KR100435247B1 (ko)	2004-09-10	나프탈렌유도체,그의제조방법,및그의중간체
Kubo et al.	1993	Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids
EP0664291B1 (en)	2000-07-19	Pyrimidine compound
FI90079C (fi)	1993-12-27	Foerfarande foer framstaellning av terapeutiskt anvaenbara bensopyranderivat
EP0126311B1 (en)	1989-09-13	Benzopyran derivatives.
US4490374A (en)	1984-12-25	5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition and method of use
AU641953B2 (en)	1993-10-07	Benzoxazine derivatives, pharmaceutical compositions containing them and processes for their production
DE69000438T2 (de)	1993-03-25	Heterocyclische derivate.
EP0558094A1 (en)	1993-09-01	Pyridine compounds for treating amnesia
SU1232145A3 (ru)	1986-05-15	Способ получени производных пиримидона или их фармацевтически приемлемых солей
CA2125725A1 (en)	1994-12-15	Urea derivative containing heterocyclic ring
JPH07101861A (ja)	1995-04-18	抗喘息薬
DD204924A5 (de)	1983-12-14	Verfahren zur herstellung n-substituierter 2-pyridylindole
CA1068698A (en)	1979-12-25	Process for preparing substituted aminoquinazoline derivatives and intermediates therefor
CA2028538A1 (en)	1991-04-28	4-substituted isoquinolone derivatives, their production and use
US4294969A (en)	1981-10-13	Process for producing 2-bromo-3,5-disubstituted pyridines
US4631283A (en)	1986-12-23	Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids
DE69715668T2 (de)	2003-07-31	N-(pyridinylamino)isoindoline und verwandte verbindungen
US4279913A (en)	1981-07-21	Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
DE69806036T2 (de)	2003-01-30	3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden
US6004977A (en)	1999-12-21	N-(pyridinylamino) isoindolines and related compounds
US4393212A (en)	1983-07-12	Certain nicotinic acid esters and corresponding nicotinonitriles
Brañ et al.	1994	Synthesis of 4-(4-pyridyl) oxazoles

Legal Events

Date	Code	Title
1998-07-15	FF	Patent granted
1998-12-06	KB	Patent renewed
1999-07-14	KB	Patent renewed
2003-10-31	RH1	Patent not in force